{"schema_version":"secwatch.filing_event.v1","accession":"0001640334-25-001742","form_type":"8-K","ticker":"LEXX","cik":"0001348362","company_name":"Lexaria Bioscience Corp.","filed_at":"2025-09-29T23:59:59+00:00","discovered_at":"2026-05-14T18:02:43.794063+00:00","generated_at":"2026-05-17T05:22:26.927480+00:00","sec_items":["1.01","3.02","8.01","9.01"],"event_type":"other_material","sentiment":"neutral","materiality_score":0.75,"calibrated_materiality_score":0.75,"confidence":"high","headline":"Lexaria closes $4M registered direct offering of 2.67M shares at $1.50 with warrants at $1.37","bullets":["Closed on Sept 29, 2025: gross proceeds of $4.0M from 2,666,667 shares at $1.50 and warrants.","Warrants for 2,666,667 shares at $1.37, immediately exercisable, 5-year term from resale registration.","Placement agent H.C. Wainwright receives 7% cash fee and 93,333 warrants at $1.875 exercise price.","Net proceeds for working capital and general corporate purposes; CEO cites 2026 R&D and BD plans."],"urls":{"canonical":"https://secwatch.observer/filing/0001640334-25-001742","json":"https://secwatch.observer/filing/0001640334-25-001742.json","markdown":"https://secwatch.observer/filing/0001640334-25-001742.md","text":"https://secwatch.observer/filing/0001640334-25-001742.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/1348362/000164033425001742/0001640334-25-001742-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/1348362/000164033425001742/lxrp_8k.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-05-17T05:22:26.927480+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}